UA98845U - Pharmaceutical composition comprising co-crystal of choline epalrestat - Google Patents

Pharmaceutical composition comprising co-crystal of choline epalrestat

Info

Publication number
UA98845U
UA98845U UAU201412435U UAU201412435U UA98845U UA 98845 U UA98845 U UA 98845U UA U201412435 U UAU201412435 U UA U201412435U UA U201412435 U UAU201412435 U UA U201412435U UA 98845 U UA98845 U UA 98845U
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
epalrestat
choline
crystal
thioco
Prior art date
Application number
UAU201412435U
Other languages
English (en)
Inventor
Isabel Kalofonos
G Patric Stahly
William Martin-Doyle
Dimitris Kalofonos
Jeffrey Stults
Travis L Houston
Original Assignee
Bionevia Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionevia Pharmaceuticals Inc filed Critical Bionevia Pharmaceuticals Inc
Priority to UAU201412435U priority Critical patent/UA98845U/ru
Publication of UA98845U publication Critical patent/UA98845U/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
UAU201412435U 2014-11-19 2014-11-19 Pharmaceutical composition comprising co-crystal of choline epalrestat UA98845U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201412435U UA98845U (en) 2014-11-19 2014-11-19 Pharmaceutical composition comprising co-crystal of choline epalrestat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201412435U UA98845U (en) 2014-11-19 2014-11-19 Pharmaceutical composition comprising co-crystal of choline epalrestat

Publications (1)

Publication Number Publication Date
UA98845U true UA98845U (en) 2015-05-12

Family

ID=53674710

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201412435U UA98845U (en) 2014-11-19 2014-11-19 Pharmaceutical composition comprising co-crystal of choline epalrestat

Country Status (1)

Country Link
UA (1) UA98845U (ru)

Similar Documents

Publication Publication Date Title
HRP20220075T1 (hr) Tekuća formulacija koja sadrži nikotin za aerosolnu primjenu
DK3236943T3 (da) Sammensætninger til ileo-jejunal lægemiddeladministration
BR112016023628A2 (pt) composições farmacêuticas.
DK3325487T3 (da) Formulering til bløde, anticholinerge analoger
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
BR112016021012A2 (pt) composições farmacêuticas de compostos terapeuticamente ativos.
DK3332767T3 (da) Flydende inhalationsformulering, der omfatter RPL554
DK3235819T3 (da) Pyrrolopyrimidinforbindelser, der er anvendelige som JAK-inhibitorer
CL2014003447S1 (es) Refrigerador.
BR112017013156A2 (pt) combinações de composto ativo.
DK3232780T3 (da) Vandige adjuvans-sammensætninger, der indeholder elektrolyt, sammensætninger, som indeholder et aktivt stof, og anvendelse deraf
BR112017012801A2 (pt) combinações de composto ativo.
BR112016026143A2 (pt) os métodos e composições compreendendo ácido 10-hidroxi-2-decenóico.
DK3394045T3 (da) Co-krystal, fremstillingsfremgangsmåde deraf og medikament som indeholder co-krystal.
DK3792251T3 (da) Hidtil ukendte sulfonylaminobenzamidforbindelser som anthelmintika
EP3153156A4 (en) Composition based on a stabilized solution of active ingredients
DK3204380T3 (da) Hidtil ukendte aminopyridinforbindelser, der er anvendelige som hæmmere af proteinprenylering
BR112016018071A2 (pt) composição de larvicida.
FR3025096B1 (fr) Composition gel/gel contenant un actif anti-transpirant
CL2016002704A1 (es) Composiciones estables de péptidos neuroactivos.
DK2915526T3 (da) Farmaceutiske sammensætninger, der omfatter anagrelid
FR3022292B1 (fr) Raidisseur tubulaire regule thermiquement
UA98845U (en) Pharmaceutical composition comprising co-crystal of choline epalrestat
CL2016003220A1 (es) Formulaciones intravaginales que comprenden gnrh.